Author

Katie Bakken

Mayo Clinic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Brandon A. WilbanksiD· 2 shared Caroline D. DohertyiD· 2 shared Danielle M. BurgenskeiD· 2 shared Jann Nagina SarkariaiD· 2 shared Lauren L. OttiD· 2 shared Louis James Maher IIIiD· 2 shared Sonia JainiD· 2 shared Brett L. CarlsoniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Brandon A. WilbanksORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Approaches to optimize cell internalization and in vivo tumor homing by aptamer-drug conjugates using SELEX

Caroline D. Doherty, Sonia Jain, Katie Bakken, Brandon A. Wilbanks, Lauren L. Ott, Brett L. Carlson, Danielle M. Burgenske, Jann Nagina Sarkaria, Louis James Maher III

This study explores optimizing aptamer-drug conjugates for GBM treatment by focusing on internalization and tumor homing through in vivo SELEX, but faces challenges with tumor specificity.

bioRxiv · Aug 26, 2026 · PreprintBiochemistry

In Vivo Selection of anti-glioblastoma DNA aptamer-drug conjugates in an orthotopic patient-derived xenograft model

Caroline D. Doherty, Sonia Jain, Lauren L. Ott, Katie Bakken, Brandon A. Wilbanks, Danielle M. Burgenske, Keenan S. Pearson, Jessica I. G. Griffith, Zichen Tian, Jeffrey A. Meridew, Saigopalakrishna S. Yerneni, William F. Elmquist, Jann Nagina Sarkaria, Louis James Maher III

This study develops and tests DNA aptamer-drug conjugates (ApDCs) for glioblastoma treatment using an in vivo SELEX approach in a patient-derived xenograft model.

NAR Cancer · Jul 27, 2026Peer-reviewedCancer Biology